Clinical features of dominant and recessive interferon γ receptor 1 deficiencies-Reference-Cited by-同舟云学术

Clinical features of dominant and recessive interferon γ receptor 1 deficiencies

Published:2004-12 Issue:9451 Volume:364 Page:2113-2121
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Dorman Susan E,Picard Capucine,Lammas David,Heyne Klaus,van Dissel Jaap T,Baretto Richard,Rosenzweig Sergio D,Newport Melanie,Levin Michael,Roesler Joachim,Kumararatne Dinakantha,Casanova Jean-Laurent,Holland Steven M

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Catalogs of human genes and genetic disorders;McKusick,1998

2. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection;Newport;N Engl J Med,1996

3. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection;Jouanguy;N Engl J Med,1996

4. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection;Jouanguy;Nat Genet,1999

5. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency;Holland;J Infect Dis,1998

Cited by 379 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of invasive mycobacterium infection with interferon beta in a patient with Interferon-Gamma Receptor 1 deficiency;Journal of Infection and Public Health;2024-08

2. Overview of infectious complications among CAR T- cell therapy recipients;Frontiers in Oncology;2024-07-03

3. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review;Journal of Allergy and Clinical Immunology;2024-05

4. Diagnosis and Management of Infections in Patients with Mendelian Susceptibility to Mycobacterial Disease;Pathogens;2024-02-25

5. Inborn errors of immunity illuminate mechanisms of human immunology and pave the road to precision medicine;Immunological Reviews;2024-02-02